Ceftriaxone & Tazobactam Injection 562.5 mg Supplier for London, United Kingdom
Premium Sterile Antibiotic Injection from India
Ernest Oncology offers Ceftriaxone & Tazobactam Injection 562.5 mg, a sterile injectable formulation containing Ceftriaxone 500 mg and Tazobactam 62.5 mg. Manufactured in India under WHO-GMP certified pharmaceutical facilities, this combination antibiotic is produced using modern sterile technology and strict quality protocols to ensure safety, purity, and consistent performance.
The medicine is formulated for intramuscular (IM) and intravenous (IV) administration under the supervision of qualified healthcare professionals.
London Pharmaceutical Market Information
London remains one of Europe's foremost healthcare and pharmaceutical hubs, supported by world-class hospitals, medical research centres, and specialist healthcare institutions. Healthcare providers continue to prioritize high-quality injectable medicines manufactured according to internationally recognized pharmaceutical standards.
India has become a trusted global source of sterile injectable medicines due to its advanced manufacturing capabilities, stringent quality control systems, and internationally accepted production practices.
Product Overview
| Product Details | Information |
|---|---|
| Product Name | Ceftriaxone & Tazobactam Injection |
| Strength | 562.5 mg |
| Composition | Ceftriaxone 500 mg + Tazobactam 62.5 mg |
| Dosage Form | Sterile Powder for Injection |
| Route of Administration | IM / IV |
| Therapeutic Class | Broad-Spectrum Antibiotic |
| Packaging | Sterile Export Packaging |
| Country of Origin | India |
Key Features
- Ceftriaxone and Tazobactam dual-action formula
- Broad-spectrum antibacterial activity
- Sterile injectable preparation
- WHO-GMP certified production
- Premium pharmaceutical-grade ingredients
- Stable and reliable formulation
- Batch-tested for quality
- Export-quality packaging
- Manufactured using advanced technology
- International quality compliance
Mechanism of Action
The two active ingredients work together to enhance antibacterial activity.
- Ceftriaxone disrupts bacterial cell wall synthesis, leading to bacterial cell destruction.
- Tazobactam inhibits beta-lactamase enzymes, helping preserve the effectiveness of Ceftriaxone against susceptible bacteria.
This complementary action provides broader antibacterial coverage when prescribed appropriately.
Recommended Dosage
The dosage should always be determined by a qualified healthcare professional.
Treatment depends upon:
- Nature of bacterial infection
- Severity of illness
- Patient age
- Body weight
- Kidney function
- Individual clinical assessment
The medicine should only be administered under professional medical supervision.
Side Effects
Some patients may experience temporary side effects during treatment.
Possible side effects include:
- Injection site discomfort
- Nausea
- Vomiting
- Diarrhea
- Headache
- Fever
- Skin rash
- Dizziness
- Allergic reactions
- Temporary elevation of liver enzymes
Consult your healthcare provider if symptoms become severe or persistent.
Safety Information
- Prescription-only medicine.
- Administer only under qualified medical supervision.
- Inform your doctor about any known allergies before treatment.
- Complete the prescribed antibiotic course.
- Follow all medical instructions carefully.
- Do not use after the expiry date.
- Keep out of reach of children.
Storage Information
- Store below 25°C
- Protect from moisture.
- Keep away from direct sunlight.
- Store in the original packaging.
- Do not freeze.
- Use before the expiry date.
Quality Assurance
At Ernest Oncology, quality remains the foundation of every product we deliver.
Our Quality Standards
- WHO-GMP certified manufacturing facilities
- Sterile manufacturing process
- Comprehensive batch testing
- Product traceability systems
- Export-quality packaging
- Controlled storage conditions
- Documentation verification
- Continuous quality monitoring
Documentation
The following documents are generally available:
- Commercial Invoice
- Packing List
- Certificate of Analysis (COA)
- Certificate of Origin (COO)
- Product Specification Sheet
- Certificate of Pharmaceutical Product (CPP)* (where applicable)
- Batch Manufacturing Record* (where available)
- Airway Bill / Bill of Lading
London Pharmaceutical Market Information
London remains one of Europe's foremost healthcare and pharmaceutical hubs, supported by world-class hospitals, medical research centres, and specialist healthcare institutions. Healthcare providers continue to prioritize high-quality injectable medicines manufactured according to internationally recognized pharmaceutical standards.
India has become a trusted global source of sterile injectable medicines due to its advanced manufacturing capabilities, stringent quality control systems, and internationally accepted production practices.
Why Choose Indian Pharmaceutical Exports
India is internationally recognized for manufacturing safe, reliable, and affordable pharmaceutical products for healthcare systems worldwide.
Advantages of Indian Pharmaceutical Manufacturing
- WHO-GMP certified manufacturing facilities
- International pharmaceutical quality standards
- Advanced sterile production technology
- Reliable batch-to-batch consistency
- High pharmaceutical purity
- Modern quality assurance systems
- Export-standard packaging
- Continuous manufacturing excellence
- Globally trusted pharmaceutical expertise
- Innovation-driven healthcare solutions
Frequently Asked Questions (FAQs)
1. What is Ceftriaxone & Tazobactam Injection 562.5 mg?
It is a sterile injectable antibiotic containing Ceftriaxone 500 mg and Tazobactam 62.5 mg, intended for treating susceptible bacterial infections under medical supervision.
2. How is this injection administered?
It is administered through intramuscular (IM) or intravenous (IV) injection by qualified healthcare professionals.
3. Why is Tazobactam combined with Ceftriaxone?
Tazobactam inhibits beta-lactamase enzymes, helping protect Ceftriaxone and improve its antibacterial effectiveness.
4. How should Ceftriaxone & Tazobactam Injection 562.5 mg be stored?
Store below 25°C, protected from moisture and direct sunlight, in its original packaging.
5. Is this medicine available without a prescription?
No. It is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.
📞 Contact Ernest Oncology — Advancing Better Healthcare Every Day
A Specialized Healthcare Division of Ernest Pharmaceutical Pvt. Ltd.
🌐 Explore Our Official Websites
- www.oncologymedicinesupplier.com
- www.ernestpharmaceuticals.com
- www.ernestvision.com
- www.ernestimpex.com
Email: exports@ernestpharmaceuticals.com
🌍 Our Vision
- Improving Global Healthcare
- Trusted Pharmaceutical Innovation
- High-Quality Medicines from India
- Excellence Through Science
+91 93599 02383
Medical Disclaimer
Ceftriaxone & Tazobactam Injection 562.5 mg is a prescription-only medicine. The information provided on this page is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using this medicine. Product availability and regulatory requirements may vary according to local regulations.
- Ceftriaxone Sodium & Tazobactam Sodium Injection
- Ceftriaxone & Tazobactam Sterile Powder for Injection
- Ceftriaxone & Tazobactam IM/IV Injection
- Ceftriaxone & Tazobactam Dry Powder Injection
- Ceftriaxone & Tazobactam Broad-Spectrum Antibiotic Injection
Description
Ernest Oncology supplies Ceftriaxone & Tazobactam Injection 562.5 mg from India to London, UK. WHO-GMP manufactured sterile antibiotic injection offering dependable pharmaceutical quality and advanced healthcare solutions.
Written By
Chaitali H.
B. Pharma
